🇮🇳IN
Sign In
SP

SPARC

NSE

Sun Pharma Advanced Research Company Ltd

₹171.77

-1.32(-0.76%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

SPARC financial summary

For Mar 2026, Sun Pharma Advanced Research Company Ltd reported revenue of ₹1,879 crore, which grew 2509.7% from the previous year. Net profit was ₹1,552 crore, on an operating margin of 85%. Earnings per share came in at ₹47.83. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹1,879 crore
Net profit₹1,552 crore
Operating margin85%
EPS₹47.83

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer